CDEK
← All organizations

Procter and Gamble

For profitContributed to NMEWebsite ↗

Also known as: P&G | P&G Pharmaceuticals | P&G Pharmaceuticals, Clinical Development Europe | Procter and Gamble | PROCTER AND GAMBLE | Procter & Gamble Beauty | Proctor and Gamble/Aventis

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

May 1, 1988

First marketed drug

Feb 6, 1953

First NDA

Feb 6, 1953

Last known activity

Aug 30, 2025

Acquired by Warner Chilcott → Actavis → Allergan PLC (2015) → AbbVie on Jan 1, 2009

Timeline

1830s

  1. Oct 1, 1837

    Procter and Gamble— Founded

1930s

  1. Jan 1, 1930

    Thomas Hedley Co— Acquired

1950s

  1. Feb 6, 1953

    nitrofurantoin— NDA Secondary Org

  2. Feb 6, 1953

    nitrofurantoin— NDA Organization

1980s

  1. Jan 1, 1982

    Norwich Eaton Company— Acquired

  2. Dec 15, 1983

    aminophylline— Marketing Organization

  3. Oct 2, 1985

    Richardson Vicks Inc— Acquired

  4. Jan 1, 1989

    Noxell— Acquired

2000s

  1. Sep 3, 2008

    Nioxin Research Laboratories— Acquired

  2. Jan 1, 2009

    Warner Chilcott— Acquired By

2010s

  1. Mar 19, 2012

    New Chapter Inc— Acquired

  2. Jun 26, 2019

    AbbVie— Now

Drugs by trial phase (55 distinct, 129 trials)

Phase 1 (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (5)

Subsidiaries (6 direct, 10 total across the full acquisition tree)

Recent trials (50)

Details

Founded
Cincinnati, OH, US Oct 1, 1837
First NDA
Feb 6, 1953
Last known activity
Aug 30, 2025

Designations held

  • Priority review